<DOC>
	<DOCNO>NCT00758212</DOCNO>
	<brief_summary>Influenza vaccination prove 's effectiveness many year usage include HIV/AIDS patient immunocompromised . In patient , however , note rise HIV viral load follow intramuscular injection vaccine unknown significance long run . Mesotherapy procedure develop practiced france reduce diluted amount antigen introduce multiple intradermal injection torso upper back . Mesotherapy mainly use vehicle introduce pain medicine cosmetic .</brief_summary>
	<brief_title>Influenza Vaccination Reduced Dose Using Mesotherapy HIV/AIDS Patients Hadassah AIDS Center , Jerusalem</brief_title>
	<detailed_description>We test effectiveness mesotherapy vehicle influenza vaccination.We use 1:10th amount seasonal trivalent influenza vaccine approx.50 HIV/AIDS patients.A control group approx.50 match patient age , treatment schedule immune status receive regular injection trivalent vaccine . We follow patient clinically symptom compatible seasonal influenza direct side effect vaccine.In addition measure anti influenza antibody two group .Follow 6 month follow vaccination.Anti influenza antibody measure 1,3,6months use hemagglutination inhibition ( HAI ) test .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Virologic diagnosis HIV/AIDS . Any immune derangement acceptable Allergy egg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Influenza Humans</keyword>
	<keyword>Acquired Immune Deficiency Syndrome</keyword>
	<keyword>Immunization , Active</keyword>
</DOC>